EMCDDA Document library

Latvian recommendations for rational pharmacotherapy for C viral hepatitis within the framework of the drug reimbursement scheme

Original/alternative title: 
C vīrushepatīta racionālas farmakoterapijas rekomendācijas zāļu iegādes kompensācijas sistēmas ietvaros

These are the Latvian government's  2017 national guidelines on diagnosis and treatment of chronic hepatitis C. Theyt  do not mention people who inject drugs (PWID) specifically. A national HCV treatment registry was initiated in 2016 in paper format and since January 2017 it is operational electronically.